Sunitinib(CAS: 557795-19-4)

Sunitinib is a multi-targeted tyrosine kinase inhibitor used in pharmaceutical applications. Its chemical formula is C19H22N4O4S, and it exhibits good solubility in DMSO and ethanol. It is known for its ability to inhibit various receptor tyrosine kinases, making it a valuable compound in drug development and research.

Sunitinib is primarily used in the treatment of certain cancers, including gastrointestinal stromal tumors (GIST) and renal cell carcinoma. As a pharmaceutical compound, it also serves as a research tool for studying kinase pathways and developing new therapeutic agents. Its versatility in targeting multiple kinases makes it a key component in drug discovery and biomedical research.

Sunitinib is generally considered safe when used under medical supervision, but it may cause side effects such as fatigue, diarrhea, and hypertension. Proper handling and adherence to safety guidelines are essential during storage and use. It is important to follow standard safety protocols to minimize exposure risks and ensure safe usage in both laboratory and clinical settings.

Sunitinib should be stored in a cool, dry place away from light. It is typically kept in a sealed container at a temperature between 2°C and 8°C. Maintaining proper humidity levels and avoiding exposure to moisture is crucial for preserving its stability and potency. Always store it in a well-ventilated area and follow recommended safety precautions.